Inventor · disambiguated record
Anne Pernille Tofteng Shelton
Also filed as: SHELTON ANNE PERNILLE TOFTENG
9 granted patents·5 pending applications·55 citations·filing 2013–2023
86Inventor score
Top patents by PatentIndex Score
14 records- 0189US10253078B2GIP agonist compounds and methodsZEALAND PHARMA AS·Filed 2015·Granted Apr 9, 2019·5 cites·18 claims
- 0288US10100097B2GIP-GLP-1 dual agonist compounds and methodsZEALAND PHARMA AS·Filed 2013·Granted Oct 16, 2018·15 cites·28 claims
- 0388US10093713B2GIP-GLP-1 dual agonist compounds and methodsZEALAND PHARMA AS·Filed 2014·Granted Oct 9, 2018·16 cites·19 claims
- 0487US10131702B2Glucagon-GLP-1-GIP triple agonist compoundsZEALAND PHARMA AS·Filed 2014·Granted Nov 20, 2018·11 cites·24 claims
- 0582US11008375B2GIP-GLP-1 dual agonist compounds and methodsZEALAND PHARMA AS·Filed 2018·Granted May 18, 2021·2 cites·6 claims
- 0680US11965039B2Compstatin analogues and their medical usesZP SPV 3 K/S·Filed 2019·Granted Apr 23, 2024·4 cites·35 claims
- 0780US11001619B2GIP agonist compounds and methodsZEALAND PHARMA AS·Filed 2019·Granted May 11, 2021·1 cites·2 claims
- 0880US2024209054A1Gip agonist compounds and methodsZEALAND PHARMA AS·Filed 2023·Application pending·0 cites
- 0974US11111285B2Glucagon-GLP-1-GIP triple agonist compoundsZEALAND PHARMA AS·Filed 2018·Granted Sep 7, 2021·1 cites·7 claims
- 1071US11814417B2GIP agonist compounds and methodsZEALAND PHARMA AS·Filed 2021·Granted Nov 14, 2023·0 cites·21 claims
- 1166US2021363213A1Glucagon-glp-1-gip triple agonist compoundsZEALAND PHARMA AS·Filed 2021·Application pending·0 cites
- 1248US2019135886A1Gip-glp-1 dual agonist compounds and methodsZEALAND PHARMA AS·Filed 2018·Application pending·0 cites
- 1344US2023287051A1Inhibitors of complement factor c3 and their medical usesZP SPV 3 K/S·Filed 2021·Application pending·0 cites
- 1440US2022306695A1Compstatin analogues and their medical usesZP SPV 3 K/S·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anne Pernille Tofteng Shelton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →